Use of Cannabinoids in the treatment of degenerative skeletal muscle diseases; F.A. Iannotti, V. Di Marzo, K. Foster, C. Scott; WO2016059411A1 (PCT/GB2015/053044)

AUTHORS:

Iannotti Fabio Arturo, Vincenzo Di Marzo, Keith Foster, Colin Scott

PATENT NUMBER:: WO2016059411A1

INTERNATIONAL PUBLICATION NUMBER: WO2016059411A1

INTERNATIONAL APPLICATION NUMBER: PCT/GB2015/053044

ABSTRACT:

The present invention relates to the use of cannabinoids in the treatment of degenerative skeletal muscle disease. In particular the degenerative skeletal muscle disease is Duchenne muscular dystrophy (DMD). Preferably the cannabinoids are one or more of: Cannabidiol (CBD); Cannabidivarin (CBDV); and Tetrahydrocannabivarin (THCV).

Research field: Human health and well-being

Branch Site: Main Research Site, POZZUOLI (NA)

Contact: Dr Iannotti Fabio Arturo

Condividi

Leave a Reply

Your email address will not be published. Required fields are marked *

* Questa casella GDPR è obbligatoria. Ho letto la policy privacy e accetto il trattamento dei miei dati personali

This site uses Akismet to reduce spam. Learn how your comment data is processed.

;